Patents by Inventor David Ferrera

David Ferrera has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11786254
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: October 17, 2023
    Assignee: COVIDIEN LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 11337714
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: May 24, 2022
    Assignee: COVIDIEN LP
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Patent number: 11197771
    Abstract: A system for removing a thrombus. The system includes an expandable device that maintains axially fixed engagement with the thrombus. The expandable device applies a first force to the thrombus according to surrounding vessel size. The expandable device applies a second force to the thrombus according to an increased vessel size to maintain axially fixed engagement.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: December 14, 2021
    Assignee: Perflow Medical Ltd.
    Inventors: David Ferrera, Avraham Rapaport, Gilad Cibulski, Mion Reiter
  • Publication number: 20210077116
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 18, 2021
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 10835257
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: November 17, 2020
    Assignee: COVIDIEN LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 10814045
    Abstract: The invention provides devices and methods for aneurysm treatment using a material that minimizes susceptibility artifacts in MRA images. Since images are not obscured by susceptibility artifacts associated with the aneurysm treatment device, those images are useful and reliable for evaluating the success of treatment. The material is preferably a non-ferromagnetic metal alloy and may include one or a combination of cobalt, nickel, chromium, and molybdenum. In certain embodiments, the material is a 35Cobalt-35Nickel-20Chromium-10Molybdenum-Low Titanium alloy medical-grade material.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: October 27, 2020
    Assignee: BALT USA
    Inventors: Randall Takahashi, David Ferrera
  • Publication number: 20190388108
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Application
    Filed: September 5, 2019
    Publication date: December 26, 2019
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Publication number: 20190365454
    Abstract: Enhanced thermal pusher assembly ensures: proper delivery of coils profiled for various applications without grounding by thermal attachment and with a handheld controller, in under one second. Attachment controller configures interface with Al, —interface and data transmission and management system.
    Type: Application
    Filed: January 8, 2018
    Publication date: December 5, 2019
    Inventors: Jake Le, David Ferrera, Randall Takahashi, Dawson Le
  • Publication number: 20190336313
    Abstract: A system for removing a thrombus. The system includes an expandable device that maintains axially fixed engagement with the thrombus. The expandable device applies a first force to the thrombus according to surrounding vessel size. The expandable device applies a second force to the thrombus according to an increased vessel size to maintain axially fixed engagement.
    Type: Application
    Filed: July 2, 2019
    Publication date: November 7, 2019
    Applicant: Perflow Medical Ltd.
    Inventors: David FERRERA, Avraham RAPAPORT, Gilad CIBULSKI, Allon REITER
  • Publication number: 20190307460
    Abstract: Aneurysm embolization devices made from laser cut NITINOL types of metals are highly differentiated by their form, which governs function, in addressing acute states of aneurysm to achieve improved clinical outcomes, namely better results with fewer devices needed, alone or in complement with conventional coils and devices.
    Type: Application
    Filed: August 24, 2016
    Publication date: October 10, 2019
    Inventors: David FERRERA, Joshua BENJAMIN
  • Patent number: 10413310
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: September 17, 2019
    Assignee: Covidien LP
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Patent number: 10383751
    Abstract: A system for removing a thrombus. The system includes an expandable device that maintains axially fixed engagement with the thrombus. The expandable device applies a first force to the thrombus according to surrounding vessel size. The expandable device applies a second force to the thrombus according to an increased vessel size to maintain axially fixed engagement.
    Type: Grant
    Filed: January 17, 2013
    Date of Patent: August 20, 2019
    Assignee: Perflow Medical Ltd.
    Inventors: David Ferrera, Avraham Rapaport, Gilad Cibulski, Allon Reiter
  • Publication number: 20190201592
    Abstract: The invention provides devices and methods for aneurysm treatment using a material that minimizes susceptibility artifacts in MRA images. Since images are not obscured by susceptibility artifacts associated with the aneurysm treatment device, those images are useful and reliable for evaluating the success of treatment. The material is preferably a non-ferromagnetic metal alloy and may include one or a combination of cobalt, nickel, chromium, and molybdenum. In certain embodiments, the material is a 35Cobalt-35Nickel-20Chromium-10Molybdenum-Low Titanium alloy medical-grade material.
    Type: Application
    Filed: October 30, 2015
    Publication date: July 4, 2019
    Inventors: Randall Takahashi, David Ferrera
  • Publication number: 20190029692
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 31, 2019
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 10123803
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: November 13, 2018
    Assignee: COVIDIEN LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Publication number: 20180271533
    Abstract: Vascular issues are addressed with systems, devices, and methods for delivering implants with accurate and ready detachability, along other features, for addressing, for example, acute stroke issues with due alacrity.
    Type: Application
    Filed: December 18, 2015
    Publication date: September 27, 2018
    Inventors: Jake Le, David A. Ferrera, Dawson Le, Randall Takahashi, George Martinez
  • Publication number: 20180271683
    Abstract: Endovascular treatment of, for example, delayed cerebral vasospasm involves the placing of a microcatheter in the affected vessels followed by the teachings of the instant disclosure, which is clinically improved with comparison to stow infusion of a vasodilating compound. Systems, processes and self-expanding designed stents and stent-like members are featured whereas as stents and stent-like members are retrieved, nothing is left in the vessel.
    Type: Application
    Filed: May 13, 2016
    Publication date: September 27, 2018
    Inventors: David A Ferrera, Joshua Benjamin, Pervinder Bhogal, Michael Sodermann
  • Patent number: 10016211
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: July 10, 2018
    Assignee: COVIDIEN LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Publication number: 20180125697
    Abstract: The present invention relates to fluid flow diversion in medical procedures, and, more particularly, to a valve assembly for preventing retrograde flow of urine from a collection device into a urinary catheter so as to reduce the risk of and/or prevent catheter-associated urinary tract infection (CAUTI). The valve assembly of the present invention is a discrete, stand-alone valve assembly configured to provide a fluid connection between a urinary catheter (e.g., Foley catheter), and a collection device (e.g., urine drainage bag) or the tubing for coupling the catheter to the collection device. The valve assembly is configured to permit antegrade flow of urine from the catheter into the collection device, while preventing retrograde flow of urine (e.g., backflow) from the collection device into the catheter, thereby reducing the risk of CAUTI.
    Type: Application
    Filed: May 10, 2016
    Publication date: May 10, 2018
    Inventor: David Ferrera
  • Publication number: 20180055666
    Abstract: Endovascular treatment of, for example, delayed cerebral vasospasm involves the placing of a microcatheter in the affected vessels followed by the teachings of the instant disclosure, which is clinically improved with comparison to slow infusion of a vasodilating compound. Systems, processes and self-expanding designed stents and stent-like members are featured and highlighted. The stents and stent-like members being retrieved, nothing is left in the vessel. Drug-eluting stents, resorbable stents and angiographically imageable coatings, including tantalum brushes over part or all of subject system components are also disclosed.
    Type: Application
    Filed: November 6, 2017
    Publication date: March 1, 2018
    Inventors: David A. Ferrera, Joshua Benjamin, Pervinder Bhogal, Michael Söderman